These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2418384)
21. CSF 5-HIAA predicts suicide risk after attempted suicide. Nordström P; Samuelsson M; Asberg M; Träskman-Bendz L; Aberg-Wistedt A; Nordin C; Bertilsson L Suicide Life Threat Behav; 1994; 24(1):1-9. PubMed ID: 7515519 [TBL] [Abstract][Full Text] [Related]
22. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. Sher L; Carballo JJ; Grunebaum MF; Burke AK; Zalsman G; Huang YY; Mann JJ; Oquendo MA Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827 [TBL] [Abstract][Full Text] [Related]
23. Rorschach ratings in depressed and suicidal patients with low levels of 5-hydroxyindoleacetic acid in cerebrospinal fluid. Rydin E; Schalling D; Asberg M Psychiatry Res; 1982 Oct; 7(2):229-43. PubMed ID: 6183703 [TBL] [Abstract][Full Text] [Related]
25. Management of depression with serotonin precursors. van Praag HM Biol Psychiatry; 1981 Mar; 16(3):291-310. PubMed ID: 6164407 [TBL] [Abstract][Full Text] [Related]
26. The relationship between CSF HVA/5-HIAA ratio and suicide intent in suicide attempters. Jokinen J; Nordström AL; Nordström P Arch Suicide Res; 2007; 11(2):187-92. PubMed ID: 17453696 [TBL] [Abstract][Full Text] [Related]
27. Neuroendocrine and neurochemical measurements in depression. Davis KL; Hollister LE; Mathé AA; Davis BM; Rothpearl AB; Faull KF; Hsieh JY; Barchas JD; Berger PA Am J Psychiatry; 1981 Dec; 138(12):1555-62. PubMed ID: 6171169 [TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Roy A; De Jong J; Linnoila M Arch Gen Psychiatry; 1989 Jul; 46(7):609-12. PubMed ID: 2472124 [TBL] [Abstract][Full Text] [Related]
29. HPT axis, CSF monoamine metabolites, suicide intent and depression severity in male suicide attempters. Jokinen J; Samuelsson M; Nordström AL; Nordström P J Affect Disord; 2008 Nov; 111(1):119-24. PubMed ID: 18342374 [TBL] [Abstract][Full Text] [Related]
30. Effects of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome. Castells S; Chakrabarti C; Winsberg BG; Hurwic M; Perel JM; Nyhan WL J Autism Dev Disord; 1979 Mar; 9(1):95-103. PubMed ID: 312282 [TBL] [Abstract][Full Text] [Related]
31. Affective disorders and aggression disorders: evidence for a common biological mechanism. van Praag HM Suicide Life Threat Behav; 1986; 16(2):103-32. PubMed ID: 2428139 [TBL] [Abstract][Full Text] [Related]
32. CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide. Jones JS; Stanley B; Mann JJ; Frances AJ; Guido JR; Traskman-Bendz L; Winchel R; Brown RP; Stanley M Am J Psychiatry; 1990 Sep; 147(9):1225-7. PubMed ID: 1696794 [TBL] [Abstract][Full Text] [Related]
33. Dexamethasone suppression test (DST) in relation to depressive somatic and suicidal manifestations. Modestin J; Ruef C Acta Psychiatr Scand; 1987 May; 75(5):491-4. PubMed ID: 3604733 [TBL] [Abstract][Full Text] [Related]
37. Cholecystokinin in CSF from depressed patients: possible relations to severity of depression and suicidal behaviour. Löfberg C; Agren H; Harro J; Oreland L Eur Neuropsychopharmacol; 1998 May; 8(2):153-7. PubMed ID: 9619694 [TBL] [Abstract][Full Text] [Related]
38. The dexamethasone suppression test and suicide prediction. Coryell W; Schlesser M Am J Psychiatry; 2001 May; 158(5):748-53. PubMed ID: 11329397 [TBL] [Abstract][Full Text] [Related]
39. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism. Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091 [TBL] [Abstract][Full Text] [Related]